Legalization of medical marijuana beneficial for cancer patients
Dec 05, 2022
A reduction was seen in the rate of one or more opioid days and in the rate of one or more pain-related hospital events.
USPSTF recommends against beta carotene, vitamin E supplements
Jun 21, 2022
No benefit was seen for cardiovascular disease or cancer prevention, and evidence was insufficient for assessing the pros and cons of multivitamins.
Stage shift seen with CT screening for lung cancer in the U.S.
Mar 31, 2022
A stage shift toward Stage I I non-small cell lung cancer was observed following the introduction of low-dose computed tomography screening for lung cancer.
Pandemic tied to drop in new cancer diagnoses
Mar 23, 2022
While weekly detection increased from March 2020 low, incidence rates have not fully recovered
Deficits in cancer screening at most facilities during pandemic
Mar 22, 2022
More than 80% of facilities reported deficits in monthly screening for colorectal cancer; there was a mean relative change of −17.7% in the monthly screening test volume.
Daily multivitamin does not cut cancer incidence in older adults
Mar 18, 2022
A same randomized two-by-two factorial trial shows that cocoa extract did not significantly reduce total cardiovascular events in older adults.
Persistent Black-white disparities seen in cancer mortality
Feb 10, 2022
Mortality rates were 41% higher for breast cancer for Black women, despite similar or lower incidence rates compared with whites.
Significant health benefits seen with meeting American Thoracic Society air quality standard
Jan 20, 2022
Compared with meeting EPA standards alone, this would prevent 11,850 more deaths, 25,400 more morbidities.
Incidence of advanced lung cancer continues to decline in the U.S.
Jan 13, 2022
During 2014 to 2018, the incidence continued to increase slowly for female breast cancer and remained stable for prostate cancer.
Blood metabolomics may detect early lung cancer
Dec 17, 2021
Predictive models were based on s comparison of serum metabolomic patterns for patients at the time of lung cancer diagnosis and matched controls.